NovaQuest invests $20m in Israeli biopharma company Mileutis

Mileutis is in advanced stages of development in the U.S., EU, and Israel of an innovative product which addresses the main concern in the dairy industry: bovine mastitis.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this